Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Scandinavian Journal of Gastroenterology|May 19, 2023
Real world for management of hepatocellular carcinoma: a large population-based studySupatsri Sethasine, Nitipon Simasingha, Sarita Ratana-Amornpin, et al.Hepatology (Baltimore, Md.)|November 24, 2011
Quantitative histological-hemodynamic correlations in cirrhosisSupatsri Sethasine, Dhanpat Jain, Roberto J Groszmann, et al.Scientific Reports|November 29, 2025
Association of noninvasive tests of liver fibrosis with chronic kidney disease in MASLD: a systematic review and meta-analysisSupatsri Sethasine, Thananda Trakarnvanich, Witchakorn Ruamtawee, et al.World Journal of Gastroenterology|September 3, 2025
Efficacy of N-acetylcysteine vs dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trialPreeyamas Koonsiripaiboon, Witchakorn Ruamtawee, Nitipon Simasingha, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 1, 2025
Liver injury in non-severe COVID-19 with various pandemic phases: A real-world studyJirayuth Winyupakorn, Chunlanee Sangketchon, Watcharaporn Devakul Na Ayutthaya, et al.World Journal of Gastroenterology|September 30, 2025
Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver diseaseSupatsri Sethasine, Padoemwut Teerawongsakul, Witchakorn Ruamtawee, et al.Scientific Reports|March 31, 2024
Intravenous metoclopramide for increasing endoscopic mucosal visualization in patients with acute upper gastrointestinal bleeding: a multicenter, randomized, double-blind, controlled trialPaveeyada Manupeeraphant, Dhanusorn Wanichagool, Thaphat Songlin, et al.Journal of Cellular and Molecular Medicine|August 2, 2011
Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressureHui-Chun Huang, Omar Haq, Teruo Utsumi, et al.BMC Gastroenterology|March 7, 2020
Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort studyPhunchai Charatcharoenwitthaya, Virasak Wongpaitoon, Piyawat Komolmit, et al.Pageof 2